Indian Market News

Markets regulator SEBI has implemented a more stringent regulatory framework for SME IPOs, introducing a profitability requirement and capping the Offer-for-Sale (OFS) component at 20%. These reforms aim to facilitate SMEs with a solid track recor

Indian stock markets have staged a significant recovery in recent trading sessions, demonstrating resilience despite weak global sentiment amid intensifying trade tensions and signs of economic slowdown in the U.S. The domestic equity markets are att

The Indian stock market broke its three-week losing streak, posting a strong rebound fueled by positive global and domestic developments, particularly surrounding US tariff-related updates. This renewed optimism among investors on Dalal Street. In

At the Moneycontrol Global Wealth Summit, a panel of leading money managers emphasized the importance of caution when investing in the broader market, noting that valuations may not have fully stabilized. Prashant Jain, a seasoned investor and fou

The finalization of the share purchase agreement for IDBI Bank's privatization is expected in March, according to a CNBC-TV18 report on March 10. Government’s Privatization Strategy Government officials stated that the Centre aims to complete

India is working to expedite a crucial bilateral trade agreement with the United States. Amid increasing concerns over the broad tariffs imposed by US President Donald Trump, recent reports indicate that officials from both nations are eager to final

The Reserve Bank of India (RBI) is likely to persist in its efforts to support the rupee, despite speculation that Governor Sanjay Malhotra might adopt a different stance, according to a report by Mint. A senior government official informed Mint t

After a five-month decline, the Indian stock market has lost its long-held valuation advantage over the U.S. For the first time since 2009, the BSE Sensex is trading at a lower price-to-earnings (P/E) ratio than the Dow Jones Industrial Average, as p

Sun Pharmaceutical Industries share, India's largest drug maker by revenue, has announced its decision to acquire Nasdaq-listed Checkpoint Therapeutics in a $355 million deal. The acquisition, confirmed on March 10, 2025, will help Sun Pharma enhance

Foreign Portfolio Investors (FPIs) persisted with their selling streak for the third consecutive month in February 2025, pulling out a total of ₹34,574 crore from the Indian equity markets, as per data from the National Securities Depository Limite

Fineotex Chemical’s stock witnessed an upward movement of more than 2% on Friday after one of its promoters increased their stake in the specialty chemicals company. The stock, which is part of ace investor Ashish Kacholia’s portfolio, climbed as

63 Moons Technologies' shares surged by 5% on the BSE, reaching ₹759.5 per share, after reports emerged that the company had reached a settlement agreement with investors in the 2013 National Spot Exchange (NSEL) payments crisis case. As part of th